CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
trifenatate (FF/UMEC/VI) with inhaled corticosteroids/long-acting beta-2 agonists (ICS/LABA) in adult participants with uncontrolled asthma...
Phase 4
Pittsburgh, Pennsylvania, United States and 67 other locations
inhaler (eMDPI) compared to ABS eMDPI in decreasing severe clinical asthma exacerbation (CAEs).Secondary Objectives:To evaluate the efficacy...
Phase 3
Pittsburgh, Pennsylvania, United States and 100 other locations
and safety of Atuliflapon administered once daily over a 12-week treatment period to adult participants with moderate to severe uncontrolled asthma...
Phase 2
Pittsburgh, Pennsylvania, United States and 350 other locations
safety, and tolerability of add-on therapy with SC lunsekimig in adult participants aged 18 to 80 years, (inclusive) with moderate-to-severe asthma...
Phase 2
Pittsburgh, Pennsylvania, United States and 62 other locations
and formoterol fumarate metered dose inhaler relative to budesonide metered dose inhaler in adults and adolescents with inadequately controlled asthma...
Phase 3
Pittsburgh, Pennsylvania, United States and 139 other locations
of clinically significant exacerbations in participants with severe asthma with an eosinophilic phenotype. Throughout the study, all partici...
Phase 3
Pittsburgh, Pennsylvania, United States and 429 other locations
variable length study to evaluate the efficacy and safety of budesonide/glycopyrronium/formoterol inhaler in adults and adolescents with severe asthma...
Phase 3
Pittsburgh, Pennsylvania, United States and 444 other locations
the efficacy and safety of budesonide and formoterol fumarate metered dose inhaler in adults and adolescents with inadequately controlled asthma...
Phase 3
Pittsburgh, Pennsylvania, United States and 180 other locations
variable length study to evaluate the efficacy and safety of budesonide/glycopyrronium/formoterol inhaler in adults and adolescents with severe asthma...
Phase 3
Pittsburgh, Pennsylvania, United States and 477 other locations
decline in adult patients with uncontrolled moderate to severe asthma.The estimated duration is 4±1 weeks of screening and run-in period, fo...
Phase 4
Pittsburgh, Pennsylvania, United States and 213 other locations
Clinical trials
Research sites
Resources
Legal